A survey of gene-specific methylation in human prostate cancer among black and white men

Cancer Letters

Volumn 205, Issue 2, 2004, Pages 181-188

  Woodson, Karen ^a   Hanson, Jeffrey ^a   Tangrea, Joseph ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Early detection; Gene methylation; Prognosis; Prostate cancer

Indexed keywords

ANNEXIN; CAVEOLIN 1; HERMES ANTIGEN; PARAFFIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UVOMORULIN;

ANGIOGENESIS; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CORRELATION ANALYSIS; DNA EXTRACTION; EDNRB GENE; ETHNIC GROUP; GENE; GENETIC ANALYSIS; GSTP1 GENE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; METHYLATION; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RARBETA2 GENE; REVIEW;

EID: 1242271225     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.11.027     Document Type: Article

References (21)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 49:1999;8-31.
2. Etzioni R., Penson D.F., Legler J.M., di Tommaso D., Boer R., Gann P.H., Feuer E.J. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J. Natl Cancer Inst. 94:2002;981-990.
3. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:2002;415-428.
4. Brooks J.D., Weinstein M., Lin X., Sun Y., Pin S.S., Bova G.S., et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol. Biomarkers Prev. 7:1998;531-536.
5. Lin X., Tascilar M., Lee W.H., Vles W.J., Lee B.H., Veeraswamy R., et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am. J. Pathol. 159:2001;1815-1826.
6. Goessl C., Krause H., Muller M., Heicappell R., Schrader M., Sachsinger J., Miller K. Fluorescent methylation-specific polymerase chain reaction for DNA- based detection of prostate cancer in bodily fluids. Cancer Res. 60:2000;5941-5945.
7. Kuzmin I., Gillespie J.W., Protopopov A., Geil L., Dreijerink K., Yang Y., et al. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res. 62:2002;3498-3502.
8. Maruyama R., Toyooka S., Toyooka K.O., Harada K., Virmani A.K., Zochbauer-Muller S., et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 61:2001;8659-8663.
9. Lou W., Krill D., Dhir R., Becich M.J., Dong J.T., Frierson H.F. Jr., et al. Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Cancer Res. 59:1999;2329-2331.
10. Nelson J.B., Lee W.H., Nguyen S.H., Jarrard D.F., Brooks J.D., Magnuson S.R., et al. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res. 57:1997;35-37.
11. Kito H., Suzuki H., Ichikawa T., Sekita N., Kamiya N., Akakura K., et al. Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer. Prostate. 49:2001;110-115.
12. Nakayama T., Watanabe M., Yamanaka M., Hirokawa Y., Suzuki H., Ito H., et al. The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers. Lab Invest. 81:2001;1049-1057.
13. Woodson K., Hayes R.B., Wideroff L., Villaruz L., Tangrea J.T. Hypermethylation of GSTP1, CD44 and E-cadherin genes in prostate cancer among US. Blacks and Whites. Prostate. 55:2003;199-205.
14. Hayes R.B., Ziegler R.G., Gridley G., Swanson C., Greenberg R.S., Swanson G.M., et al. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol. Biomarkers Prev. 9:1999;25-34.
15. Li L.C., Zhao H., Nakajima K., Oh B.R., Filho L.A., Carroll P., Dahiya R. Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J. Urol. 166:2001;705-709.
16. Rennie P.S., Nelson C.C. Epigenetic mechanisms for progression of prostate cancer. Cancer Metastasis Rev. 17:1998;401-409.
17. Nelson J.B., Carducci M.A. The role of endothelin-1 and endothelin receptor antagonists in prostate cancer. B. J. U. Int. 85:2000;45-48.
18. Jeronimo C., Henrique R., Campos P.F., Oliveira J., Caballero O.L., Lopes C., Sidransky D. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J. Clin. Pathol. 56:2003;52-55.
19. Chetcuti A., Margan S.H., Russell P., Mann S., Millar D.S., Clark S.J., et al. Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res. 61:2001;6331-6334.
20. Cui J., Rohr L.R., Swanson G., Speights V.O., Maxwell T., Brothman A.R. Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate. 46:2001;249-256.
21. Goessl C., Muller M., Heicappell R., Krause H., Straub B., Schrader M., Miller K. DNA-based detection of prostate cancer in urine after prostatic massage. Urology. 58:2001;335-338.